BRF
NVAX icon

B. Riley Financial’s Novavax NVAX Stock Holding History

B. Riley Financial’s Portfolio NVAX Stock Details NVAX Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2019
Q2 		– Sell
-6,517
Closed -$72K – 66
2019
Q1 		$72K Sell
6,517
-15,100
-70% -$477K 0.03% 82
2018
Q4 		$796K Buy
21,617
+3,657
+20% +$142K 0.44% 30
2018
Q3 		$675K Buy
17,960
+4,665
+35% +$131K 0.19% 79
2018
Q2 		$357K Buy
13,295
+12,770
+2,432% +$432K 0.09% 208
2018
Q1 		$22K Hold
525
– – 0.01% 289
2017
Q4 		$13K Hold
525
– – ﹤0.01% 309
2017
Q3 		$12K Hold
525
– – ﹤0.01% 303
2017
Q2 		$12K Hold
525
– – ﹤0.01% 214
2017
Q1 		$13K Buy
+525
New +$14.4K 0.01% 150
2016
Q4 		– Sell
-525
Closed -$22K – 149
2016
Q3 		$22K Hold
525
– – 0.01% 145
2016
Q2 		$76K Hold
525
– – 0.04% 132
2016
Q1 		$54K Hold
525
– – 0.04% 127
2015
Q4 		$88K Buy
+525
New +$80.8K 0.06% 123

Other funds holding NVAX

BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
Northern Trust
Northern Trust Chicago, Illinois $757B AUM 28.64% 1-Year Est. Return
Two Sigma Advisers
Two Sigma Advisers New York $51.4B AUM 31.07% 1-Year Est. Return
RSCM
Rock Springs Capital Management Baltimore, Maryland $1.7B AUM 93.03% 1-Year Est. Return
Charles Schwab
Charles Schwab San Francisco, California $654B AUM 26.35% 1-Year Est. Return
Bank of New York Mellon
Bank of New York Mellon New York $544B AUM 28.31% 1-Year Est. Return

B. Riley Financial's NVAX Position: Q2 2019 in Review

B. Riley Financial sold out of Novavax (NVAX) in Q2 2019, closing a stake of 6,517 shares — an estimated $72K sold.

B. Riley Financial first reported a position in NVAX in Q4 2015 and held it in 13 quarters. The position peaked at $796K in Q4 2018. 81 funds tracked by Wall St. Rank hold NVAX as of Q2 2019.

  • B. Riley Financial reported no remaining Novavax position as of Q2 2019 after selling out during the quarter.
  • B. Riley Financial sold 6,517 Novavax shares in Q2 2019, an estimated $72K.
  • B. Riley Financial first reported a position in Novavax in Q4 2015 and held it in 13 quarters.
  • B. Riley Financial's Novavax position peaked at $796K in Q4 2018.
  • 81 funds tracked by Wall St. Rank held Novavax as of Q2 2019.

Based on B. Riley Financial's 13F filing for Q2 2019, filed 12 Aug 2019.